[go: up one dir, main page]

WO2003008012A8 - Procede et dispositif de preparation du sang - Google Patents

Procede et dispositif de preparation du sang

Info

Publication number
WO2003008012A8
WO2003008012A8 PCT/EP2002/007855 EP0207855W WO03008012A8 WO 2003008012 A8 WO2003008012 A8 WO 2003008012A8 EP 0207855 W EP0207855 W EP 0207855W WO 03008012 A8 WO03008012 A8 WO 03008012A8
Authority
WO
WIPO (PCT)
Prior art keywords
preparing blood
chambers
containers
suspension samples
cryobanks
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2002/007855
Other languages
German (de)
English (en)
Other versions
WO2003008012A2 (fr
WO2003008012A3 (fr
Inventor
Michael Eck
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hibernia AG
Original Assignee
Hibernia AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hibernia AG filed Critical Hibernia AG
Priority to AU2002331254A priority Critical patent/AU2002331254A1/en
Publication of WO2003008012A2 publication Critical patent/WO2003008012A2/fr
Publication of WO2003008012A3 publication Critical patent/WO2003008012A3/fr
Anticipated expiration legal-status Critical
Publication of WO2003008012A8 publication Critical patent/WO2003008012A8/fr
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/02Blood transfusion apparatus
    • A61M1/029Separating blood components present in distinct layers in a container, not otherwise provided for
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/02Blood transfusion apparatus
    • A61M1/0209Multiple bag systems for separating or storing blood components

Landscapes

  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Vascular Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pathology (AREA)
  • Centrifugal Separators (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
  • Sampling And Sample Adjustment (AREA)

Abstract

L'invention concerne un dispositif de préparation (100) servant à traiter des échantillons en suspension, notamment pour préparer des cryoconserves de sang. Ledit dispositif comprend un système d'au moins deux récipients pour contenir des échantillons en suspension, des parties d'échantillon et/ou des additifs. Les récipients se présentent sous forme de chambres (13 à 15, 90) avec des parois fixes et sont disposés de manière fixe les uns par rapport aux autres. Il est prévu un dispositif de transfert (20) comportant au moins une conduite de connexion (22), par l'intermédiaire de laquelle les chambres (13 à 15) peuvent être interconnectées.
PCT/EP2002/007855 2001-07-18 2002-07-15 Procede et dispositif de preparation du sang Ceased WO2003008012A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002331254A AU2002331254A1 (en) 2001-07-18 2002-07-15 Device and method for preparing blood

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10134913.0 2001-07-18
DE10134913A DE10134913C2 (de) 2001-07-18 2001-07-18 Vorrichtung und Verfahren zur Blutpräparation

Publications (3)

Publication Number Publication Date
WO2003008012A2 WO2003008012A2 (fr) 2003-01-30
WO2003008012A3 WO2003008012A3 (fr) 2003-04-03
WO2003008012A8 true WO2003008012A8 (fr) 2004-06-10

Family

ID=7692196

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2002/007855 Ceased WO2003008012A2 (fr) 2001-07-18 2002-07-15 Procede et dispositif de preparation du sang

Country Status (3)

Country Link
AU (1) AU2002331254A1 (fr)
DE (1) DE10134913C2 (fr)
WO (1) WO2003008012A2 (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7939316B2 (en) * 2006-06-20 2011-05-10 Bio Technology, LLC Systems and methods for cryopreservation of cells
US8709797B2 (en) 2006-06-20 2014-04-29 Cook General Biotechnology Llc Systems and methods for cryopreservation of cells
US8535241B2 (en) 2011-10-13 2013-09-17 Magnolia Medical Technologies, Inc. Fluid diversion mechanism for bodily-fluid sampling
US9022951B2 (en) 2012-05-30 2015-05-05 Magnolia Medical Technologies, Inc. Fluid diversion mechanism for bodily-fluid sampling
US9060724B2 (en) 2012-05-30 2015-06-23 Magnolia Medical Technologies, Inc. Fluid diversion mechanism for bodily-fluid sampling
US9204864B2 (en) 2012-08-01 2015-12-08 Magnolia Medical Technologies, Inc. Fluid diversion mechanism for bodily-fluid sampling
ES2878047T3 (es) 2012-10-11 2021-11-18 Magnolia Medical Technologies Inc Sistema para administrar un fluido a un paciente con contaminación reducida
US9155495B2 (en) 2012-11-30 2015-10-13 Magnolia Medical Technologies, Inc. Syringe-based fluid diversion mechanism for bodily fluid sampling
CA3183294A1 (fr) 2012-12-04 2014-06-12 Magnolia Medical Technologies, Inc. Dispositif sterile de recueil de fluide corporel et procedes
US10772548B2 (en) 2012-12-04 2020-09-15 Magnolia Medical Technologies, Inc. Sterile bodily-fluid collection device and methods
FR3028771B1 (fr) * 2014-11-24 2021-12-24 Inst Nat De La Rech Agronomique Inra Dispositif d'extraction de liquide depuis une substance, notamment depuis des graines oleagineuses
EP3307359B1 (fr) 2015-06-12 2020-07-01 Gregory J. Bullington Appareil pour transfert de fluide par seringue pour échantillonnage de fluide corporel
US10010282B2 (en) 2015-07-24 2018-07-03 Kurin, Inc. Blood sample optimization system and blood contaminant sequestration device and method
EP4249119A3 (fr) 2015-09-03 2023-11-29 Magnolia Medical Technologies, Inc. Système de maintien de la stérilité d'un récipient d'échantillon
US10827964B2 (en) 2017-02-10 2020-11-10 Kurin, Inc. Blood contaminant sequestration device with one-way air valve and air-permeable blood barrier with closure mechanism
US20180353117A1 (en) 2017-06-09 2018-12-13 Magnolia Medical Technologies, Inc. Fluid control devices and methods of using the same
IL273025B2 (en) 2017-09-12 2024-12-01 Magnolia Medical Technologies Inc Fluid control devices and methods of using them
CA3087992A1 (fr) 2017-12-07 2019-06-13 Magnolia Medical Technologies, Inc. Dispositifs de regulation de fluide et leurs procedes d'utilisation
CN111498355B (zh) * 2019-01-31 2025-08-15 青岛海特生物医疗有限公司 转盘式自动化血液存储装置及存取方法
US11786155B2 (en) 2019-02-08 2023-10-17 Magnolia Medical Technologies, Inc. Devices and methods for bodily fluid collection and distribution
US11857321B2 (en) 2019-03-11 2024-01-02 Magnolia Medical Technologies, Inc. Fluid control devices and methods of using the same
JP7554206B2 (ja) 2019-04-01 2024-09-19 クリン インコーポレイテッド 非通気性体液サンプル最適化装置及びシステム

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3185154A (en) * 1962-08-14 1965-05-25 Joseph F Caccavo Apparatus for collecting, separating, storing and dispensing whole blood
WO1988003045A1 (fr) * 1986-10-31 1988-05-05 North American Biologicals, Inc. Separation cryogenique amelioree de globuline
JPH039754A (ja) * 1989-06-07 1991-01-17 Daihachi Matsuura 密閉混合容器
US5674394A (en) * 1995-03-24 1997-10-07 Johnson & Johnson Medical, Inc. Single use system for preparation of autologous plasma
NZ336397A (en) * 1997-01-08 2001-01-26 Bristol Myers Squibb Co Centrifuge apparatus comprising a piston displaceable in a cylindrical member and an optical blood cell detector
DE29805538U1 (de) * 1998-03-26 1998-06-04 Gebauer GmbH Gerätebau-Elektronik, 75242 Neuhausen Blutbeutel-Handler
CN1182882C (zh) * 1998-12-24 2005-01-05 生物安全股份有限公司 特别用于浓缩造血干细胞的血液分离系统

Also Published As

Publication number Publication date
DE10134913C2 (de) 2003-06-26
DE10134913A1 (de) 2003-02-20
WO2003008012A2 (fr) 2003-01-30
AU2002331254A1 (en) 2003-03-03
WO2003008012A3 (fr) 2003-04-03

Similar Documents

Publication Publication Date Title
WO2003008012A8 (fr) Procede et dispositif de preparation du sang
CA2378148A1 (fr) Trifluorobutenes nematicides
WO2001064920A3 (fr) Expressions hybrides de proteines de neisseria
WO2003019131A3 (fr) Procede et dispositif de preparation d'un prelevement d'origine biologique pour determiner au moins un constituants
WO2001034835A3 (fr) Procede de production de biopolymeres a proprietes modifiees
CA2439222A1 (fr) Procede permettant d'identifier des agonistes partiels du recepteur a2a
AU2002249534A1 (en) Nanocomposites, process for their preparation and products made therefrom
WO2000058005A3 (fr) Immuno-adsorbants pour le traitement de la septicemie
EP1120047A4 (fr) Procede de traitement de soja utilisant une enzyme, soja traite ainsi obtenu et aliment contenant le soja ainsi traite
AU7410600A (en) Method for the determination of substances using the evanescence field method
WO2002006242A3 (fr) 2-aryl-4-pyrimidinones 5-substituees
EE05303B1 (et) Konjugaat, selle valmistamine ning meetod selles sisalduva molekuli transportimiseks l„bi bioloogilise membraani
CA2336375A1 (fr) Amidon modifie, stable vis-a-vis du sel
FR2833259B1 (fr) Procede de preparation de 2-arylbenzofuranes, composes intermediaires, 2-arylbenzofuranes et compositions les comprenant
AU2002365269A1 (en) Mut-il-18 or mut-il-18r proteins, antibodies, compositions, methods and uses
WO2004042341A3 (fr) Procede pour acheminer des echantillons de suspension a des chambres a echantillons
PL364927A1 (en) Compositions and methods for l-nucleosides, l-nucleotides, and their analogs
WO2001036946A8 (fr) Ensemble capteur
WO2002010752A3 (fr) Puces de detection a couches multiples de polysiloxane
PL369718A1 (en) Process for the preparation of (1,4,5)-oxadiazepine derivatives
AU2001283146A1 (en) Batch process for refining used oil
TWI318213B (en) Polyamide nucleic acid derivatives, and agents and processes for preparing them
WO2000059862A3 (fr) Procedes destines a la preparation de produits intermediaires pesticides
AU2002306748A1 (en) Anti-gpe antibodies, their uses, and analytical methods for gpe
AU2002346403A1 (en) Method for selective conjugation of analytes to enzymes without unwanted enzyme-enzyme cross-linking

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: IN PCT GAZETTE 05/2003 UNDER (71) REPLACE "APPLICANT (FOR US ONLY)" BY "APPLICANT (FOR ALL DESIGNATED STATES EXCEPT US)"

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: FESTSTELLUNG EINES RECHTSVERLUSTS NACH REGEL 69 (1) EPUE VOM 10.08.04 HIERNA AG, I PARK KLINGHOLZ 17, 97232 GIEBELSTADT

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase in:

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP